protein 937 words KG: APOLIPOPROTEINERECEPTOR2 2026-03-21
kind:proteinsection:proteinsstate:published
Contents

ApoER2 Protein

🔬 Protein Info
Gene SymbolLRP8
AliasesLDLRR, LR8, APOER2
Chromosome1p31.3
Protein TypeReceptor
FunctionNeuronal migration: Reelin-LRP8/Dab1 signaling regulates cortical lamination
Primary ExpressionBrain (neurons), testis, platelets
Molecular Weight~110 kDa (full-length), 85 kDa (truncated)
Amino Acids870 aa
Exons31
PathwaysCardiovascular Homeostasis
UniProt IDQ9UBJ2
Ensembl IDENSG00000157193
GeneCardsLRP8
Human Protein AtlasLRP8
Protein NameApolipoprotein E Receptor 2 (ApoER2)
Associated DiseasesALS, Aging, Alzheimer, Atherosclerosis, Cancer
InteractionsTRKB, AKT, APOA1, APOE, CYP46A1, ABCA1
KG Connections192 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (16)

Cholesterol-CRISPR Convergence Therapy for Neurodegeneration
Score: 0.48
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Related Analyses (11)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived

Related Experiments (7)

AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.40
Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40

See Also (15)

ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT
clinical · Pages share 9 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 9 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 9 hypotheses
APOE4 (Apolipoprotein E4)
disease · Pages share 8 hypotheses
APOE3 (Apolipoprotein E3)
disease · Pages share 8 hypotheses